Comment
doi: 10.1073/pnas.1010365107.
Epub 2010 Aug 16.
Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed
Affiliations
- PMID: 20713719
- PMCID: PMC2930528
- DOI: 10.1073/pnas.1010365107
Item in Clipboard
Comment
Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed
Proc Natl Acad Sci U S A.
.
No abstract available
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15229-34. doi: 10.1073/pnas.1008986107. Epub 2010 Jul 26. Proc Natl Acad Sci U S A. 2010. PMID: 20660766 Free PMC article.
Similar articles
-
Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.J Mol Model. 2016 Apr;22(4):90. doi: 10.1007/s00894-016-2944-x. Epub 2016 Mar 28. J Mol Model. 2016. PMID: 27021209
-
Molecular biology and pharmacology of galanin receptors.Ann N Y Acad Sci. 1998 Dec 21;863:94-107. doi: 10.1111/j.1749-6632.1998.tb10687.x. Ann N Y Acad Sci. 1998. PMID: 9928163 Review.
-
Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities.Ann N Y Acad Sci. 1998 Dec 21;863:450-3. doi: 10.1111/j.1749-6632.1998.tb10721.x. Ann N Y Acad Sci. 1998. PMID: 9928197 No abstract available.
-
Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding.Ann N Y Acad Sci. 1998 Dec 21;863:78-85. doi: 10.1111/j.1749-6632.1998.tb10685.x. Ann N Y Acad Sci. 1998. PMID: 9928161
-
Chemistry and molecular biology of galanin receptor ligands.Ann N Y Acad Sci. 1998 Dec 21;863:86-93. doi: 10.1111/j.1749-6632.1998.tb10686.x. Ann N Y Acad Sci. 1998. PMID: 9928162 Review. No abstract available.
Cited by
-
Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.J Mol Model. 2016 Apr;22(4):90. doi: 10.1007/s00894-016-2944-x. Epub 2016 Mar 28. J Mol Model. 2016. PMID: 27021209
References
-
- Hökfelt T, Bartfai T, Bloom F. Neuropeptides: Opportunities for drug discovery. Lancet Neurol. 2003;2:463–472. - PubMed
-
- Vezzani A, et al. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 1994;660:138–143. - PubMed
-
- Vezzani A, Hoyer D. Brain somatostatin: A candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci. 1999;11:3767–3776. - PubMed
-
- Noè F, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain. 2008;131:1506–1515. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
